CX1739 is an investigational new drug developed by Cortex Pharmaceuticals that is being evaluated for the treatment of a wide range of conditions such ADHD, autism, opioid-induced respiratory depression, and central sleep apnea.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.